Enzyme Replacement Therapy Market Scope And Analysis

Report Code : TIPRE00008474
Category : Life Sciences

Status : Published
No. of Pages : 226

Buy Now

Enzyme Replacement Therapy Market Scope and Key Players Analysis by 2028

Buy Now

Enzyme Replacement Therapy Market Report Scope

Report Attribute	Details
Market size in 2021	US$ 9.67 Billion
Market Size by 2028	US$ 15.18 Billion
Global CAGR (2021 - 2028)	6.8%
Historical Data	2019-2020
Forecast period	2022-2028
Segments Covered	By Enzyme Type Alglucosidase Alfa Agalsidase Beta Imiglucerase Idursulfase Galsulfase Velaglucerase Alfa Other Enzymes By Therapeutic Conditions Gaucher's Disease Fabry's Disease MPS Pompe's Disease SCID Other Therapeutic Conditions By Route of Administration Parenteral and Oral By End User Hospitals Infusion Centers
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Sanofi BioMarin Pharmaceutical Inc Takeda Pharmaceutical Company Limited AbbVie Inc Janssen Pharmaceuticals Johnson Johnson Services Inc Alexion Pharmaceuticals Inc AstraZeneca Amicus Therapeutics Recordati S p A CHIESI Farmaceutici S p A

End User-Based Insights

Based on end user, the global enzyme replacement therapy market is segmented into hospitals, infusion centers, and others. The hospitals segment held the largest market share in 2021. However, the infusion centers segment is expected to register the highest CAGR during the forecast period.

The global enzyme replacement therapy market players adopt organic strategies, including product launch and expansion, to expand their footprint and product portfolio worldwide and meet the growing demand. A few major players contributing to the market are Takeda Pharmaceutical Company Limited; Sanofi S.A.; AbbVie Inc.; BioMarin Pharmaceutical Inc.; Amicus Therapeutics; Alexion Pharmaceuticals, Inc. (AstraZeneca); Janssen Pharmaceuticals (Johnson & Johnson Services, Inc.); Recordati S.p.A.; Pfizer Inc.; and CHIESI Farmaceutici S.p.A.